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Voltage-gated sodium, potassium, and calcium
channels are made of a pore domain (PD) controlled
by four voltage-sensing domains (VSDs). The PD
contains the ion permeation pathway and the acti-
vation gate located on the intracellular side of the
membrane. A large number of small molecules are
known to inhibit the PD by acting as open channel
blockers. The voltage-gated proton channel Hv1 is
made of two VSDs and lacks the PD. The loca-
tion of the activation gate in the VSD is unknown
and open channel blockers for VSDs have not
yet been identified. Here, we describe a class
of small molecules which act as open channel
blockers on the Hv1 VSD and find that a highly con-
served phenylalanine in the charge transfer center
of the VSD plays a key role in blocker binding. We
then use one of the blockers to show that Hv1
contains two intracellular and allosterically coupled
gates.INTRODUCTION
The Hv1 voltage-gated proton channel (also known as HVCN1 or
VSOP) is a member of the superfamily of proteins containing
voltage-sensing domains (VSDs) (Ramsey et al., 2006; Sasaki
et al., 2006). These domains are made of four membrane-
spanning segments (S1 through S4), and their function is to
detect changes in membrane potential in both excitable and
nonexcitable cells (Figure 1A) (Okamura, 2007; Yu and Catterall,
2004). Voltage-gated sodium, potassium, and calcium channels
are also VSD-containing proteins. They are all made of a pore
domain (PD) responsible for selective ion permeation, and four
VSDs. A gate located on the intracellular side of the PD (known
as activation gate) opens and closes as a function of membrane
potential due to direct interaction with the VSDs (Hille, 2001)
(Figure 1B).
The Hv1 channel does not have a pore domain and its VSD is
responsible for proton permeation (Lee et al., 2009; Ramsey
et al., 2006; Sasaki et al., 2006). The S4 segment, which
contains voltage-sensitive arginines highly conserved in other274 Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc.voltage-gated ion channels, is directly connected to a C-termi-
nal coiled-coil domain (Figure 1A). Hv1 has been shown to form
dimers in which two VSD subunits are held together by the
coiled-coil domain (Figures 1A and 1B) (Koch et al., 2008; Lee
et al., 2008; Li et al., 2010; Tombola et al., 2008). The deletion
of the Hv1 N and C-terminal domains, as well as the substitu-
tion of these domains with the corresponding parts of the
voltage-sensitive phosphatase Ci-VSP (Murata et al., 2005),
were found to produce monomeric channels capable of
voltage-dependent proton conduction, indicating that the
gating machinery is contained in each VSD (Koch et al., 2008;
Tombola et al., 2008). The nature of this gating machinery
and the location of the activation gate in the VSD are still
unknown.
Open channel blockers are inhibitors that bind the ion perme-
ation pathway of a channel only when its gate is open (Hille,
2001). We reasoned that if open channel blockers were available
for ion permeable VSDs, they could be used to study the gating
mechanism of Hv1 and, in particular, to locate the activation gate
in the VSD. Here, we describe guanidine derivatives that bind the
Hv1 channel from the intracellular side of the membrane and act
as potential channel blockers. We find that the most effective
of these compounds, 2-gunaidiniumbenzimidazole (2GBI), can
access the core of the VSD only when the channel is in the
open conformation and that the highly conserved phenylalanine
150 in the S2 transmembrane helix plays a key role in blocker
binding. We then use mutations at position 150 to characterize
the interaction between the blocker and the VSD gating
machinery.
As previously shown for the pore domain, we find that the acti-
vation gate of the VSD is located on the intracellular side of the
membrane and that when 2GBI is bound to its receptor the
gate cannot close (‘‘foot in the door’’ mechanism of block). By
comparing the recovery from block of dimeric and monomeric
Hv1 channels, we find that once one of the two subunits releases
its blocker, the state of its gate determines the rate of blocker
unbinding from the neighboring subunit. We discuss the struc-
tural implications of this mechanism of block for the VSD’s intra-
cellular vestibule, and for the coupling between the gates in the
channel’s two subunits.
The Hv1 channel is known to play important roles in proton
extrusion, pH homeostasis, and production of reactive oxygen
species in a variety of cell types (Capasso et al., 2011). It has
been recently implicated in cancer development (Wang et al.,
2012) and brain damage during ischemic stroke (Wu et al.,
Figure 1. Gating of a VSD Pore Probed with
Intracellular Blockers
(A) Topology of VSD-containing channels with and
without a pore domain (PD). CCD: coiled-coil
domain.
(B) Voltage-dependent opening and block of PD
(top) and VSD (bottom). The Hv1 channel contains
two conducting VSDs. The location of its activation
gates is not known, nor is the mechanism of VSD
block. Only two of the four Kv VSDs are shown for
clarity.
(C) Guanidine derivatives tested as potential Hv1
intracellular blockers. [1] Guanidine, [2] amino-
guanidine, [3] 2-aminoimidazole, [4] 2-aminopyri-
midine, [5] agmatine, [6] 2-aminobenzimidazole,




zothiazol-2-yl)guanidine. Guanidine moieties are
highlighted in blue in compounds 1–7. The parts of
compound 7 that are conserved in compounds
8–12 are also highlighted in blue.
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VSD Block in the Hv1 Channel2012). Understanding how compounds like guanidine deriva-
tives interact with the channel’s VSD and block proton con-
duction is an important step toward the development of
pharmacological treatments for diseases caused by Hv1 hyper-
activity. In addition, it can provide important clues on how to
block VSDs of other voltage-gated ion channels when they
become ion permeable as a result of naturally occurring muta-
tions (Sokolov et al., 2007).Neuron 77, 274–287RESULTS
Inhibition of Hv1 Channels by the
Guanidine Derivative 2GBI
Guanidinium was previously found to
permeate the VSDs of mutated voltage-
gated sodium and potassium channels
(Sokolov et al., 2010; Tombola et al.,
2005), and to inhibit Hv1 without shifting
the channel’s activation curve (Tombola
et al., 2008). Because of its structural
similarity to the S4 voltage-sensing argi-
nines, guanidinium appeared to be a
good starting compound to develop
inhibitors that bind to the core of the
VSD. Guanidinium is effective at inhibiting
proton currents in the millimolar con-
centration range. We hypothesized that
more complex molecules containing the
guanidine moiety could have a higher
binding affinity for Hv1. We screened
guanidine derivatives with different steric
features (Figure 1C) on inside-out patches
from Xenopus oocytes expressing the
human Hv1 channel. The proton current
elicited by depolarization to +120 mV
was measured before and after additionof each compound to the bath solution at the final concentration
of 200 mM (Figures 2A–2C). Compounds 3, 5, 6, 7, 9, and 12
were found to be more effective at inhibiting Hv1 than guanidi-
nium (compound 1), while the other compounds were equally
or less effective than guanidinium. The inhibition was fully
reversible for all the compounds. With the exception of
compound 4, the protonated and positively charged forms of
the tested inhibitors are expected to be the most abundant in, January 23, 2013 ª2013 Elsevier Inc. 275
Figure 2. Inhibition of Proton Channel Activity by Guanidine Derivatives
(A) Proton currents measured in an inside-out patch from a Xenopus oocyte expressing WT human Hv1 before (black trace) and after (red trace) addition 2GBI
(compound #7) in the bath solution (200 mM). Teal trace (overlapping black trace) is the current measured after inhibitor washout. Currents were activated by
depolarizations to +120 mV from a holding potential of 80 mV. pHi = pHo = 6.0. The current measured at the end of the depolarization step (black triangle) was
used to produce plots like the one shown in (B).
(B) Time courses of inhibition produced by 200 mM intracellular 2GBI (black circles), or by 500 mM extracellular 2GBI (gray diamonds). Solid bars indicate the
presence of the inhibitor in the bath during measurements performed in inside-out (black), or outside-out (gray) patch configuration.
(C) Average inhibition produced by the indicated compounds (numbers as in Figure 1) added intracellularly (200 mM).
(D) Dose dependence of 2GBI inhibition for proton channels of the indicated species. Curves are Hill fits of the data points (see Table S1).
(E) G-V relationships for human Hv1 in the presence and absence of 200 mM 2GBI (pHi = pHo = 6.0.). Teal and red curves are Boltzmann fits (see Table S2). Gray
line is the G-V in the presence of the inhibitor normalized to the control maximal conductance (no inhibitor).
(F) Effect of extracellular pH on proton channel inhibition by 50 mM intracellular 2GBI (pHi = 6.0). Error bars are ± SEM, nR 4.
See also Figures S1 and S2.
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VSD Block in the Hv1 Channelsolution at the pH used for the measurements (see Figure S1
available online).
We first examined compounds 1 through 7 and found that
when the guanidine structure was part of a five-membered
aromatic ring, the resulting inhibitors blocked the proton current
more effectively than guanidinium alone (e.g., compounds 3 and
6 in Figures 1C and 2C). The presence of a second guanidine
group, conjugated with the one on the ring, in compound 7
(2GBI) further increased the affinity for the channel (Figures 1C
and 2A–2D). We then examined compounds 8 through 12 to
gain insight on the molecular features that make 2GBI the most
effective inhibitor. Compounds 8, 9, and 10 share with 2GBI
the conjugated double guanidine substructure but were not as
effective as 2GBI at inhibiting the proton channel. Compounds
11 and 12 differ from 2GBI and from each other only at one posi-
tion in the five-membered ring. However, compound 12 inhibited
the proton current almost as effectively as 2GBI while compound
11 was even less effective than simple guanidinium. These
results indicate that the binding site for guanidine derivatives
on the proton channel is highly selective.276 Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc.Transient application of 2GBI on the intracellular side of the
membrane while the channels were held open at +120 mV re-
sulted in fast current reduction (Figure S2A). Transient applica-
tion of the compound before the channels were opened had no
effect on the current elicited by subsequent depolarization (Fig-
ure S2A). When 2GBI was applied before the depolarization step
and maintained throughout the recording, the current reached
a steady-state level of inhibition with the same kinetics of
channel opening. The same steady-state level was reached
more rapidly when the inhibitor was applied during the depolar-
ization step (Figure S2B).
2GBI failed to inhibit the outward Hv1 current elicited by depo-
larization at +120 mV and the inward tail current generated
during membrane repolarization at 80 mV when added to the
bath solution in outside-out patch configuration (Figures 2B,
S2C, and S2D). The strong sensitivity of Hv1 to intracellular
2GBI and the lack of sensitivity to extracellular 2GBI (measured
over the same timescale and concentration range) imply that
the binding site on the channel is directly accessible only
from the intracellular side of the membrane. However, slow
Neuron
VSD Block in the Hv1 Channelmembrane crossing by guanidine derivatives has been previ-
ously observed (Kalia and Swartz, 2011). So, we cannot exclude
that longer treatments with extracellular 2GBI than the ones
tested here could result in Hv1 inhibition.
To determine whether the binding site for 2GBI is located in
a structurally conserved part of the protein, we compared the
dose dependence of inhibition of the human channel to the
dose dependences of inhibition of Ci-VSOP, the channel from
the tunicate Ciona intestinalis (Sasaki et al., 2006), and
Eh-HVCN1, the channel from the coccolithophore Emiliana
huxleyi (Taylor et al., 2011) (Figure 2D; Table S1). Ci-VSOP and
Eh-HVCN1 conduct protons through their VSDs like the human
Hv1, and they are 27% and 18% identical to the human protein,
respectively. Despite some differences in IC50 (38 mM for the
human Hv1, 52 mM for Ci-VSOP, and 87 mM for Eh-HVCN1),
2GBI was able to completely inhibit the three channels within
similar concentration ranges indicating that the binding site has
been maintained over evolution. Given the higher sensitivity of
the human Hv1 for 2GBI, we continued our study of the mecha-
nism of inhibition with this channel.
2GBI Interaction with the Open VSD
We then asked whether 2GBI acts as an allosteric modulator like
other known Hv1 inhibitors (Alabi et al., 2007; DeCoursey and
Cherny, 2007), or as a channel blocker. If 2GBI inhibits the Hv1
current by making channel opening more difficult, its binding
should alter the channel’s voltage dependence of activation.
We verified this by comparing the G-V curves of Hv1 in the pres-
ence of 200 mM 2GBI and in the absence of the inhibitor. The
curves were obtained from tail current measurements as previ-
ously described (Musset et al., 2008; Tombola et al., 2010) and
were found to be superimposable (Figure 2E; Table S2). The
finding that 2GBI reduces the channel’s maximal conductance
without altering its G-V curve and the observation that channels
already opened by depolarization can be quickly inhibited by fast
application of 2GBI (Figures S2A and S2B) are consistent with
a mechanism of inhibition in which 2GBI blocks open channels.
We also found that the efficiency of Hv1 block by intracellular
2GBI increased when the concentration of protons on the extra-
cellular side of themembrane decreased (higher pHo) (Figure 2F),
suggesting that the blocker binds in the channel’s pore where it
can interact with permeating protons. To gain more insight on
whether 2GBI has access to the proton permeation pathway
inside the VSD, we analyzed the effects of the transmembrane
electric field and extracellular protons on 2GBI inhibition.
Because of its positive charge, 2GBI is expected to be sensi-
tive to the transmembrane electric field when binding to the
channel. This means that its apparent dissociation constant
(KD) should depend on the membrane potential. We determined
the voltage dependence of KD by measuring the proton current
carried by maximally open channels in the presence of 50 mM
2GBI at different membrane potentials (Figures 3A and 3B),
and by using as reference the KD measured from the dose-
response curve of Figure 2D at +120 mV (see Supplemental
Experimental Procedures, Equations S4 and S5). From the
exponential fit of the KD-voltage relationship the parameter dzb
(effective charge) of 0.35 ± 0.1was calculated (see Supplemental
Experimental Procedures, Equation S6), which provides an esti-mate of the maximal fraction of the transmembrane electric field
that the blocker must cross in order to reach its binding site
inside the channel (Woodhull, 1973). Considering a relative
drop in membrane potential from 1 to 0 across the entire Hv1
proton permeation pathway, a dzb of 0.35 means that the
charged 2GBI molecule (zb = +1) experiences up to 35% of the
total electric field when moving in and out of the proton pore.
If 2GBI binds the VSD on the intracellular side of the perme-
ation pathway, protons entering the channel from the ex-
tracellular side are expected to facilitate blocker unbinding.
Accordingly, an increase in extracellular proton concentration
(decrease in pHo) is expected to cause an increase in the rate
of blocker unbinding at negative potentials, resulting in a faster
decay of the tail current. To test the effect of extracellular protons
on blocker unbinding, we compared the decays of the tail current
at 40 mV measured at two different extracellular pHs (Fig-
ure 3C). We first determined the pHo dependence of channel
closing by measuring the ratio between the time constants of
current decays at pHo 7.5 and 6.0 in the absence of the blocker
(t7.5/t6.0 1.5). Then, we determined the pHo dependence of
channel unblocking by similar measurements carried out in
the presence of 200 mM 2GBI in the intracellular solution
(see Supplemental Experimental Procedures). As expected, we
found that increasing the extracellular proton concentration
significantly shortens the decay time of the tail current in the
presence of the blocker (t7.5/t6.02.6) (Figure 3D). This is consis-
tent with blocker unbinding facilitated by extracellular protons in
the permeation pathway.
F150 Plays a Key Role in 2GBI Binding
Since 2GBI appears to bind the Hv1 channel somewhere along
the permeation pathway, we planned to use it to shed light on
the location of the pore. We wondered whether we could find
residues in the channel that, when mutated, would strongly
affect 2GBI binding. We had previously identified a mutant of
the Shaker potassium channel that conducts ions—including
guanidinium—through its VSD (Tombola et al., 2005) and had
found several residues that are likely to line the Shaker VSD
pore (Tombola et al., 2007). We hypothesized that among the
Hv1 residues homologous to those involved in ion permeation
in the Shaker VSD there could be some that face the proton
pore and participate in the binding of 2GBI. Of all the Shaker
mutations tested for their impact on the ion current (omega
current) flowing through the VSD, those at position F290
produced the strongest effect (Tombola et al., 2007). In addition,
F290 was proposed to be part of the occlusion (charge transfer
center) that prevents ions from flowing through nonconducting
VSDs (Tao et al., 2010). The Hv1 residue F150 corresponds to
the Shaker F290. The phenylalanine is located deep within the
membrane in the S2 helix, and it is highly conserved in the
VSDs of voltage-gated ion channels and voltage dependent
phosphatases. We mutated F150 to several other residues and
found that the alanine substitution produced a 360-fold
increase in binding affinity for 2GBI (Figure 4 and Table S1).
The cysteine substitution also increased the affinity for the
blocker, but to a lesser extent (Figure 4C). On the other hand,
the dose dependence of block of Hv1 F150W was very similar
to the wild-type (WT) channel (Figure 4C). These findings showNeuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc. 277
Figure 3. 2GBI Binding and Unbinding Depend on Membrane Potential and Extracellular Proton Concentration
(A) Proton currents from Hv1 channels measured in inside-out patches in the absence of blocker (Control) and in the presence of 50 mM 2GBI in the bath solution
(pHi = pHo = 6.0). Patches with similar current levels were selected for the comparison and scaled to match themaximal current. A depolarization to +140mVwas
followed by a step to a progressively lower voltage, in 10mV decrements. Holding potential was80mV. The color of the traces transitions from gray to red as the
test voltage becomes more positive.
(B) Apparent dissociation constant of 2GBI block as a function of membrane potential, calculated from proton currents recorded using the voltage protocol
described in (A). Error bars are ± SEM, n = 6. The exponential fit of the data is shown as black line.
(C) Hv1 tail-currents measured from two outside-out patches in response to a voltage step to 40 mV from a preceding depolarization at +120 mV (not shown).
pHi was 6.0. For each patch, currents weremeasured at a pHo of 6.0 and 7.5. Traces on the right weremeasured in the presence of 200 mM2GBI in the intracellular
(pipette) solution.
(D) Average values of the ratio of time constants of current decay measured at pHo = 7.5 and 6.0, from traces like those reported in (C). Time constants were
calculated from multiexponential fits of current decays. A t7.5/t6.0 > 1 means that the decay is faster when the proton concentration is higher on the extracellular
side of the pore.
Error bars are SEM, nR 4.
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the strength of the interaction between the channel and 2GBI.
In Shaker, mutations at position F290 were found to alter the
voltage dependence of gating, producing shifts in the conduc-
tance versus voltage relationship (G-V curve), and alterations
of the gating charge movement in the VSD (Lacroix and Beza-
nilla, 2011; Tao et al., 2010). We determined the G-V curves of
Hv1 F150A, F150C, and F150W and compared them to the
G-V of the WT channel (Figure 4B; Table S2). We found that
mutation F150Wproduced the strongest perturbation of channel
gating (largest G-V shift compared to WT), and yet it had almost
no effect on 2GBI binding. In contrast, mutations F150A and
F150C produced different effects on 2GBI binding, but the
same effect on channel gating (very similar G-V curves). We
conclude that there is no correlation between the alterations of
channel gating and affinity for the blocker produced by F150
substitutions. This suggests that the mechanism by which278 Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc.F150 mutations alter 2GBI binding is distinct from the mecha-
nism by which they alter the movement of the voltage sensor.
Selectivity of the Perturbations of F150 Substitutions
We examined whether the increase in affinity for 2GBI resulting
from mutations at position 150 was dependent on the structure
of the inhibitor. We compared the relative block of F150A
and WT channels by 2GBI to the relative block of the same two
channels by other two intracellular inhibitors: guanidinium and
magnesium. Guanidinium was selected for the comparison
because it lacks the 2GBI structural feature provided by the
benzimidazole group. Magnesium was selected because it was
found to inhibit the Hv1 proton current despite being structurally
unrelated to 2GBI and guanidinium. We found that, while there is
a large difference in binding affinity for 2GBI between F150A and
WT channels, there is a much smaller difference for guanidinium
and no difference for magnesium (Figure 4D).
Figure 4. Effects of F150 Substitutions on
Hv1 Voltage Dependence and Inhibition by
Intracellular Blockers
(A) Proton currents measured from F150A
Hv1 channels in response to depolarizations
to +120 mV from a holding potential of 80 mV
(pHi = pHo = 6.0.). After recording the current from
an inside-out patch in the absence of the inhibitor
(black trace), 2GBI (2 mM) was added to the bath
solution (dark red trace) and then removed by bath
perfusion (gray trace). Red and orange traces
show partial recovery from block during inhibitor
washout.
(B) Conductance versus voltage relationships for
the indicated F150 mutants compared to WT (see
Table S2).
(C) Dose dependence of 2GBI inhibition of F150A,
F150C, and F150W channels compared to WT.
Curves are Hill fits (see Table S1).
(D) Inhibition of Hv1 F150A and WT by 1 mM 2GBI,
compared to inhibition by guanidinium (500 mM)
and magnesium (7.9 mM).
(E) Dose dependence of inhibition by 2GBOZ
(compound #11) of F150A and F150C channels
compared to WT. Curves are Hill fits (see Table
S1). Extrapolation of the WT inhibition curve at
concentrations higher than the solubility limit of
2GBOZ is shown as dashed line. Error bars
are ± SEM, n R 4 (not shown when smaller than
symbols).
(F) Location of phenylalanine 150 (red side chain) in
the two structural models of the Hv1 VSD from
Wood et al. (2012) (R1-model in green, and R2-
model in blue). The models were superimposed by
distance minimization of the alpha carbons of the
S1 segments (residue 99–123). The VSD is shown
from the intracellular side of the membrane plane.
(G) Interpretation of the result shown in (A) as state
dependent block regulated by the opening of an
activation gate.
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channels by 1-(1,3-benzoxazol-2-yl)guanidine (GBOZ) (com-
pound 11 in Figure 1). This inhibitor is very similar to 2GBI in
structure, but it is a weak blocker like magnesium (both GBOZ
and magnesium have IC50s close to 9 mM). We found that the
F150A and F150C mutations altered the affinity of the channel
for GBOZ in the same way that they altered the affinity for
2GBI (Figure 4E). This shows that the nature of the side chain
of residue 150 affects the interaction between the channel and
the inhibitor in a selective manner, with 2GBI and closely related
compounds being affected the most.Neuron 77, 274–287Opening of an Intracellular Gate Is
Required for 2GBI Binding
When Hv1 WT is treated with 2GBI, the
proton current is inhibited, and the
apparent rate of channel deactivation is
slowed down, producing a more persis-
tent inward current at negative voltages
after depolarization (Figures 2A and
S2C). A similar phenomenon is observedwith other voltage-gated ion channels when their pore domain
interacts with intracellular blockers. When the intracellular acti-
vation gate of the pore domain is closed, blockers are prevented
from reaching a binding site located in the core of the permeation
pathway. If the channel opens and the blocker is allowed to bind,
the gate cannot close until the blocker unbinds. This is referred to
as foot in the door effect (Yeh and Armstrong, 1978), and it is also
seen with the inactivation ball of some fast inactivating channels
(Hille, 2001). The apparent rate of channel deactivation is slowed
down by the foot in the door effect because the gate cannot
close right away upon membrane repolarization and must, January 23, 2013 ª2013 Elsevier Inc. 279
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VSD Block in the Hv1 Channelinstead wait for the blocker (or the inactivation ball) to first vacate
the pore.
The foot in the door effect of 2GBI on the Hv1 deactivation rate
suggests that there is an intracellular gate in the VSD also.
However, when channels with intracellular gates are opened in
the presence of a blocker, the time course of current activation
usually displays a biphasic behavior. Upon depolarization, the
current first raises, reaches a maximum, and then falls to
a steady-state level that depends on the affinity and concen-
tration of the blocker. This is observed, for example, when
voltage-gated potassium channels are blocked by intracellular
quaternary-ammonium inhibitors (Armstrong, 1968, 1971; Choi
et al., 1993), or by the inactivation ball (Armstrong and Bezanilla,
1977; Demo and Yellen, 1991; Zagotta et al., 1990). The biphasic
behavior is a direct result of gate opening. At the beginning of the
depolarization, most channels are closed and cannot bind the
blocker. Open channels are generated faster than they are
blocked and the current increases. Over time, as the pool of
closed channels decreases, the production of open channels
slows down and the blocking process becomes dominant, with
consequent decrease in the current.
When 2GBI inhibits Hv1 WT, there is no sign of a biphasic
behavior in the activation current (Figure 2A). The proton current
increases upon depolarization with similar kinetics in the pres-
ence and in the absence of the blocker. However, when 2GBI
inhibits Hv1 F150A, it produces a strong change in the kinetics
of the activation current, which becomes clearly biphasic (Fig-
ure 4A). This, in combination with the prominent slowdown of
the deactivation current, provides strong evidence for the regu-
lation of 2GBI block by an intracellular gate (Figure 4G).
The behavior of Hv1 F150A also helps explain why 2GBI does
not affect the kinetics of activation in the WT channel. The slow-
opening process in Hv1 WT does not allow a transient accumu-
lation of open channels in the presence of 2GBI. The channels
simply get blocked as soon as they open, making it impossible
for the current to display the biphasic time course. The F150A
mutation changes all this, directly, by speeding up the opening
process (compare time scales in Figures 2A and 4A), and indi-
rectly, by lowering the concentration of 2GBI required for
inhibition (increased affinity), which results in a slower rate of
channel block.
Coupling between Gates in the Two Hv1 Subunits
To further investigate the interaction between 2GBI and the Hv1
intracellular gate, we examined the recovery from block of
the F150A mutant with a two-pulse voltage protocol (Fig-
ure 5A). The current measurements were performed in inside-
out patches and in the presence of 400 nM blocker in the bath
solution. The channels were opened and blocked with the first
depolarization pulse. They were then unblocked by applying
a negative voltage, and the fraction of recovery from block was
tested with a second depolarization pulse. The time between
the two pulses (tIP) spent at negative voltage was varied to
capture the time course of recovery (Figures 5A–5C). This was
determined by reporting the relative increase in peak current at
the test pulse as a function of tIP.
When tIP is short, only a few channels have the time to recover
from block before the second depolarization. This is expected to280 Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc.result in a peak current in the second pulse similar in magnitude
to the current at the end of the first pulse. When tIP becomes
longer, the channels have more time to recover and the peak
current in the second pulse should gradually increase until there
is no more difference between the first and second peaks (com-
plete recovery). This is the typical behavior of current recovery
from block/inactivation observed in voltage-gated channels
with pore domains. But, Hv1 F150A recovers from 2GBI block
in a significantly different way. As tIP increases, the second
peak increases very fast and reaches a maximum value that is
higher than the first peak. Then, at longer tIP, the second peak
slowly decays to reach the value of the first peak (Figures 5A
and 5C). In addition, the recovery peak currents measured at
short and long tIP display very different kinetics of opening and
block (compare peaks 1 and 2 in Figure 5D, and values of tdecay
in Figure 5E). If the recovery peaks were produced only by the
opening of nonblocked channels, they should only change in size
as a function of tIP, but their kinetics should stay the same. The
difference in kinetics indicates that different populations of chan-
nels are responsible for the recovery peaksat short tIP versus long
tIP. The significant delay between the time at which the recovery
peaks reach their maximum and the time at which the tail current
is maximal (Figures 5A and S5A) suggests that a significant frac-
tion of the recovery current comes from a population of channels
that are not able to conduct current at negative potentials but can
become conductive very rapidly at positive potentials.
While voltage-gated sodium, potassium, and calcium chan-
nels contain one activation gate in the pore domain, Hv1 is
made of two subunits that can gate cooperatively (Fujiwara
et al., 2012; Gonzalez et al., 2010; Musset et al., 2010; Tombola
et al., 2010). We considered that the presence of two coupled
gates in Hv1 could be the reason for its peculiar recovery from
block. We first tested this hypothesis by examining the recovery
from block of monomeric Hv1 F150A. Monomerization was
achieved as previously described by replacing Hv1 intra-
cellular N and C termini with the corresponding parts of Ci-VSP
(Tombola et al., 2008). We found that the NVSP-Hv1-CVSP
F150A chimera recovers from block similarly to channels with
pore domains, with the current of the second peak gradually
rising to the level of the first peak as tIP increases (Figures 5B
and 5C). Moreover, the kinetics of opening and block of the
recovery peaks measured at short and long tIPs were the same
in monomeric channels (Figures 5D and 5E).
Models of Channel Block in Dimeric andMonomeric Hv1
We examined the recovery from block by simulating the gating
process in the presence of 2GBI with kinetic schemes involving
one gate (monomer) (Figure S3), or two coupled gates (dimer)
(Figure 6). We assumed that each subunit can exist in three
different states: closed (C), open (O), or blocked (B). This pro-
duces a total of nine states in dimeric channels: CC, OC (equiv-
alent to CO), OO, BO (equivalent to OB), BC (equivalent to CB),
and BB (Figure 6A). Since we found that 2GBI must wait for the
activation gate to open in order to block the channel, we
assumed that the blocked state can only be reached from the
open state in each individual subunit.
We had previously established that the opening of one Hv1
subunit strongly facilitates the opening of the other subunit
Figure 5. Recovery from Block of Hv1 F150A: Dimer versus Monomer
(A) Proton currents from F150A Hv1 channels in the presence of 400 nM 2GBI measured in response to the indicated two-pulse voltage protocol. The time interval
between depolarization pulses (tIP) was progressively increased from 0.05 to 8 s. The trace recorded with the shortest tIP is not displayed for clarity. The voltage
was stepped from 60 mV to +140 mV in both pulses. Holding potential between sweeps was 80 mV.
(B) Proton currents from monomeric F150A NVSP-Hv1-CVSP chimera, measured under the same conditions as in (A).
(C) Fractional recovery from block as a function of tIP calculated from peak currents measured as shown in (A) and (B). Red filled circles are for F150A Hv1. Black
open circles are for the F150A NVSP-Hv1-CVSP chimera. Red line is a double-exponential fit of the data points for the dimer. Black line is a monoexponential fit of
the data points for the monomer.
(D) The first and last recovery peaksmarked as 1 and 2 in (A) and (B) (tIP = 0.2 s and 8 s, respectively) are compared. The peaks are superimposed andmagnified to
show their kinetics.
(E) Apparent time constants of 2GBI block during the second pulse of two-pulse protocols. The constants were measured bymonoexponential fit of the decaying
current in recovery peaks 1 (black columns) and 2 (gray columns). Error bars are ± SEM, nR 4.
See also Figure S3.
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opening in the kinetic model of dimeric Hv1 was required to
reproduce the observed time course of recovery from block.
This was accomplished by making opening transitions from
states with one gate already open (e.g., OC/ OO, and BC/
BO) faster than equivalent transitions from states with both gates
closed (e.g., CC/ OC). In order to reproduce the experimental
findings, the model needed to include also the following proper-
ties of channel block: (1) when the blocker is bound to one
subunit, the gate of that subunit cannot close (foot in the door),
and (2) if the gate of an unblocked subunit happens to close while
the neighboring subunit is still bound to the blocker, it becomes
significantly harder for that blocker to unbind. The first property
was represented in themodel by excluding transitions of the type
BX/ CX (with X = C, O, or B). The second property was repre-
sented by a slower rate of unblocking in dimers with one closed
subunit (e.g., BC/ OC) compared to the rate of unblocking indimers with two open or blocked subunits (e.g., BO / OO,
BB/ OB).
We found that the kinetic model shown in Figures 6A and S4
can reproduce the major features of channel block and recovery
from block of dimeric F150A Hv1. It can also be simplified
to reproduce the observed behavior of monomeric channels
(Figures S3 and S4). The simplified model features only three
states (C, O, and B), loses the properties connected to the coop-
erative gating between subunits, but maintains the general
feature of the foot in the door mechanism of block.
Using the kinetic model for the F150A dimeric channel, we
were also able to reproduce the behavior of 2GBI block in the
WT channel (Figure 6D). Hv1 WT is characterized by a slower
rate of opening and a lower affinity for 2GBI compared to the
F150A mutant. To account for these differences, adjustments
in the rates of opening and block were necessary (see Figure S4).
When we reduced the rates of opening and adjusted the rates ofNeuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc. 281
Figure 6. Model of Hv1 Opening and Block Mediated by Two
Coupled Intracellular Gates
(A) States of the two gates of the Hv1 dimer during opening. CC, close-closed;
OC, open-closed; BC, blocked-closed; OO, open-open; BO, blocked-open;
BB, blocked-blocked. Only forward reactions favored at positive potentials are
shown for clarity.
(B) Simulation of currents from modeled F150A dimeric channels generated
under conditions equivalent to those reported in Figure 5A. The currents were
generated using the kinetic rates reported in Figure S4.
(C) Superimposition of the first and last recovery peaks marked as 1 and 2 in
(B). For analogous simulations of currents from F150A monomeric channels
see Figure S3.
(D) Simulated currents from the indicated channels in response to a depolar-
ization step to +120mV from a holding potential of80mV before and after the
addition of 2GBI (400 nM for Hv1 F150A and 200 mM for Hv1WT). The currents
were generatedwith the same kineticmodel but with different rate constants to
account for the slower gating, lower 2GBI binding affinity, and faster block-
ing and unblocking of the WT channel compared to the F150A mutant (see
Figure S4).
See also Figures S4 and S5.
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282 Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc.blocking and unblocking to account for the higher concentration
of 2GBI required for block, the biphasic time course of the simu-
lated current of F150A channels (Figure 6D, left panel) turned into
the simpler time course of theWT current (Figure 6D, right panel).
State-Dependent Release of 2GBI from Dimeric Hv1
An important feature of 2GBI block highlighted by the modeling
of Hv1 dimers is that, once a subunit releases its blocker, the
state of its gate determines the fate of the blocker in the neigh-
boring subunit. If the gate is open, the blocker in the other
subunit is released quickly. If the gate is closed, the blocker is
released slowly. We call this phenomenon ‘‘hemichannel blocker
trapping’’ because the closing of one subunit (hemichannel
formation) ‘‘traps’’ the blocker in the neighboring subunit. The
trapping of the blocker was critically important for the simulation
of the recovery fromblock of F150A dimers (Figure S4).We found
that only models in which the BC / OC transition was much
slower than the BO / OO transition (blocker trapping in BC
dimers) were able to describe the experimental data. The rate
of the BC/ OC transition at negative potential was the param-
eter with the largest effect on the heights and shapes of the
recovery peaks as a function of tIP.
2GBI slows down the tail currents of Hv1 channels by causing
a delay in gate closure. The contribution of hemichannel blocker
trapping to this delay depends on the fraction of BC dimers
generated. Our model indicates that the fraction of BC dimers
formed at negative potentials is higher in F150A channels
compared to WT channels because of the higher rate of blocker
unbinding from WT subunits. Fast unblocking means that both
subunits can release their blockers before the gate in either
subunit can close (Figure S4). This transiently produces dimers
with two open subunits and limits the formation of BC dimers
in WT. The model also predicts that blockers with lower
unbinding rate (higher binding affinity) than 2GBI will produce
larger fractions of WT BC dimers.
The features of the interactions between 2GBI and the VSD of
Hv1 are similar to those previously described for open-channel
blockers of pore domains. But, the trapping of the blocker in
one subunit caused by gate closing in the neighboring subunit
seems to be a unique feature of Hv1, due to the existence of
two distinct activation gates on two allosterically coupled ion-
permeable VSDs.
Blocker Trapping Tested in Heteromeric F150A-WT
Channels
We tested the conclusion that the recovery from block of Hv1
channels is delayed by 2GBI trapping in BC dimers under exper-
imental conditions in which the formation of BC dimers is maxi-
mized. To do this, we maximized the fraction of BO dimers from
which BC dimers are formed during the recovery from block at
negative potentials. Generating large fractions of BO channels
in WT or F150A homodimers is difficult because, even at 2GBI
concentrations that produce 50% of channel block, significant
fractions of dimers are in the OO and BB states at the end of
the depolarization step. So, we generated linked heterodimers
made of one F150A subunit and one WT subunit and exploited
the large difference in 2GBI affinity between the two subunits
to generate BO dimers. Based on the apparent dissociation
Figure 7. Hemichannel Blocker Trapping for 2GBI Tested in a Heterodimeric Hv1 Channel
(A) Partial 2GBI block of linked heterodimersmade of one F150A subunit (dark red) and oneWT subunit (gray). Currents traces from an inside-out patch containing
F150A-WT dimers. Channels were opened by depolarization to +120 mV (from 80 mV holding potential) in the absence of the inhibitor (black trace), and in the
presence of 2 mM 2GBI (red trace) in the intracellular solution (pHi = pHo = 6.0). Gray line is the predicted current contributed by the F150A subunit after 2GBI
addition, obtained by multiexponential fitting of the total current measured in the presence of blocker (red trace). At the end of the depolarization, the large
majority of channels are in the BO state when 2GBI is present. Uponmembrane repolarization, BO channels can be converted to either BC or OO channels. Black
arrow indicates favored conversion.
(B) Tail currents from linked dimers measured in response to the indicated voltage ramp after the depolarization step described in (A).
(C) Partial 2GBI block of linkedWT-WT homodimers. Currents traces weremeasured under the conditions described in (A) but using 40 mM2GBI. At the end of the
depolarization step the channels are distributed among the BB, OO, and BO/OB states. Upon membrane repolarization the conversion from BO channels to OO
channels is favored (black arrow).
(D) Tail currents from linked WT-WT dimers measured in response to the indicated voltage ramp after a depolarization step to +120 mV (same conditions
described in C).
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VSD Block in the Hv1 Channelconstants of 2GBI from F150A and WT homodimers, we esti-
mated that 2 mM 2GBI should block about 94% of the F150A
subunits and 6% of the WT subunits at +120 mV, producing
a 50% total inhibition of the initial current (Figure 7A). After
the depolarization step to +120 mV, the membrane was repolar-
ized with a voltage ramp from 080 mV, and the time course of
the tail current was recorded before and after addition of 2GBI
(Figure 7B).
The number of open subunits decreases over time after the
end of the depolarization step due to gate closing. However,
the current flowing through each individual open subunit
increases during the ramp, due to the increased electrical driving
force for proton movement. These two opposing factors deter-
mine the position and size of the negative peak of the tail current.
We reasoned that if the blocker was trapped in BC dimers, its
slow release would delay the formation of open hemichannels(OC) during the voltage ramp. These hemichannels would
conduct more current than those formed at the beginning of
the ramp and would cause the peak of the tail current to increase
in size and to shift its position to more negative voltages. We
indeed observed an increase in the tail current produced by
2GBI in the F150A-WT dimers and a right shift in the position
of the peak (Figure 7B).
We then repeated the same kind of measurements in WT-WT
linked dimers using a 2GBI concentration of 40 mM to inhibit 50%
of the current at +120 mV (Figures 7C and 7D). We observed
a small reduction in the tail current during the repolarization
ramp induced by the blocker and a small shift of the peak toward
more negative potentials (Figure 7D). This is in agreement with
the idea that the fraction of BC dimers produced from BO dimers
in WT-WT channels is reduced due to the competition of the
process that converts BO dimers into OO dimers (Figure 7C).Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc. 283
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Compounds that act as inhibitors of pore domains have been
used for decades to investigate the permeation and gating
mechanism of voltage-gated sodium, potassium, and calcium
channels (Hille, 2001). For example, the use of open channel
blockers such as quaternary ammonium ions and cationic deriv-
atives of local anesthetics led to the discovery that the activation
gate of these channels faces the inner side of the membrane
(e.g., Armstrong, 1971; Holmgren et al., 1997; Narahashi et al.,
1969). Here, we find that some heteroaromatic guanidine deriv-
atives are effective inhibitors of the Hv1 proton channel and
show that one of these compounds, 2GBI, acts as an open
channel blocker of the VSD.
The voltage dependence of VSD block by intracellular 2GBI
and the effect of extracellular protons on the rate of blocker
unbinding indicate that the binding site for 2GBI is located in
the channel’s permeation pathway. The finding that the chan-
nel’s affinity for the blocker depends on the nature of the side
chain at position 150 in the core of the VSD supports this conclu-
sion, which is also in agreement with the recent finding that non-
derivatized guanidinium ions can permeate the Hv1 channel
when one of its S4 arginines (R211) is mutated to a different
amino acid (Berger and Isacoff, 2011). From the analysis of
channel block in Hv1 WT and F150A, we found that 2GBI needs
to wait for the opening of an intracellular gate in order to gain
access to the permeation pathway in the VSD, and that as long
as the blocker is bound to its receptor, the gate cannot close.
The increased affinity of the F150A channel for 2GBI and its
faster kinetic of activation allowed us to investigate the recovery
from block of dimeric and monomeric forms of Hv1. We found
that when the open subunit of BO dimers closes, producing
BC dimers, the release of 2GBI from the blocked subunit
becomes substantially slower, as if the blocker was trapped
inside the channel (hemichannel blocker trapping). We then
analyzed the effect of 2GBI on the tail currents of F150A-WT
linked dimers to confirm the delayed release of the trapped
blocker.
Relative Stability of Hv1 Conformations and Blocker
Trapping
The results of our simulations of Hv1 block support the idea that
conformations in which the gates of the two subunits are out of
sync (e.g., OC, and BC) are less stable than the conformations
in which the gates are in sync (e.g., OO, CC, and BB). The
energetic bias toward in-sync conformations could be due to
mechanical stress between the two gates when one is open
and the other is closed and can provide an explanation for the
observed cooperativity between subunits during gating of Hv1
dimers (Fujiwara et al., 2012; Gonzalez et al., 2010; Musset
et al., 2010; Tombola et al., 2010). The phenomenon of hemi-
channel blocker trapping can then be interpreted as a result of
block-induced stabilization of BC dimers. In these dimers, the
gate in the blocked subunit cannot close, forcing the two
subunits to be out of sync. But, the blocked subunit can change
conformation to increase the affinity for the blocker (8-fold),
and the stabilization of the channel associated with the tighter
block can compensate for the destabilization caused by the284 Neuron 77, 274–287, January 23, 2013 ª2013 Elsevier Inc.stress between gates. This suggests that blockers capable of
producing a strong stabilization of the hemichannel would be
able to stay bound for a long time after channel activation,
causing use-dependent cumulative block.
Relationship between F150 the Hv1 Selectivity Filter
and the Gate
Unlike other ions, protons can move in aqueous solutions
and within channel proteins via proton-hoping mechanism
(Decoursey, 2003). The exact role played in proton-hoping by
water inside the VSD (Ramsey et al., 2010; Wood et al., 2012)
and by charged residues lining its pore is not well understood.
But, recent studies have identified an aspartate in the middle
of the S1 segment and the third S4 arginine (residues D112
and R211 in the human Hv1) as two key players in the ion selec-
tion mechanism (Berger and Isacoff, 2011; Musset et al., 2011).
The region containing these two residues is likely to be the
narrowest part of the permeation pathway.
Here, we find strong evidence that 2GBI binds in proximity of
phenylalanine 150 in the S2 segment when blocking the proton
pore. Different structural models of the Hv1 channel suggest
that F150 is located just below D112 and R211 (or R3) in the
core of the VSD (Ramsey et al., 2010; Wood et al., 2012), in other
words, below the narrowest part of the permeation pathway.
F150 corresponds to residue F233 in the Kv1.2-2.1 paddle
chimera (Long et al., 2007). In the crystal structure of the potas-
sium channel, F233 is located right on top of a cluster of tightly
packed residues in which the fifth S4 charge (K5) interacts with
two acidic residues in S2 and S3. Our findings suggest that in
the Hv1 open conformation the corresponding cluster of tightly
packed residues below the conserved phenylalanine is replaced
by a vestibule large enough to accommodate the 2GBI blocker.
This structural feature may be due to the lack of the fourth
and fifth S4 charges in Hv1 and it is consistent with the idea
that the narrowest part of the permeation pathway of the Hv1
channel—the selectivity filter—is located above F150, toward
the extracellular side of the membrane.
In the pore domain, the activation gate and the selectivity filter
are located on opposite sides of the membrane and so they are
separated by a relatively large distance. In the VSD, selectivity
filter and gate are likely to be much closer in space given the
smaller size of the domain and the proximity of F150 to D112
and R211. In this context, the state dependence of 2GBI block
could derive from the widening of the edges of the intracellular
vestibule in the open state, which would allow the blocker to
interact with a deeper binding site. Alternatively, it could derive
from the formation of the intracellular binding site in the open
state by the gating machinery.
Conclusions
The intracellular cavity of the pore domain can accommodate
blockers of large size, including bulky quaternary ammonium
ions. The intracellular vestibule of Hv1 on the other hand seems
to fit guanidine derivatives like a tight glove. Even small differ-
ences in the structure of the blocker result in large variations in
binding affinity (e.g., 2GBI versus GBOZ). Intracellular quater-
nary ammonium ions like TMA+ and TEA+ do not inhibit the
Hv1 channel (Musset et al., 2011; Ramsey et al., 2006), either
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or because they lack the proper chemical properties for a tight
binding. Exploring the specific interactions between guanidine
derivatives and the intracellular vestibule of the Hv1 VSD will
help develop inhibitors with higher affinity and selectivity for
the channel.
Recently, Hv1 was found to be highly expressed in breast
cancer cells, and its knockdown by RNA interference was shown
to strongly reduce cell proliferation and invasiveness (Wang
et al., 2011, 2012). Hv1 was also found to be involved in NOX-
mediated neuronal death during cerebral ischemia, and mice
lacking Hv1 activity were shown to be protected from brain
damage after stroke (Wu et al., 2012). These findings highlight
the importance of understanding how Hv1 works at the molec-
ular level and how it can bemodulated or blocked by small mole-
cules like guanidine derivatives. The development of high-affinity
inhibitors for Hv1 could lead to new chemotherapeutics and
treatments for ischemic stroke.
The VSDs of voltage-gated sodium and potassium channels
do not conduct ions under physiological conditions, but they
can become ion permeable as a result of mutations in the voltage
sensor (Sokolov et al., 2005; Starace and Bezanilla, 2004; Tom-
bola et al., 2005). Ion/proton currents flowing through one of the
VSDs of mutated Nav1.4 channels have been found to be the
cause of some periodic paralyses (Sokolov et al., 2007; Struyk
and Cannon, 2007). Mutations of voltage-gated ion channels
associated with other genetic diseases have been proposed to
result in ion conducting VSDs (Sokolov et al., 2007). Determining
how the Hv1 channel is gated and how it interacts with small
molecules could help design drugs able to block ‘‘leaky’’ VSDs.
EXPERIMENTAL PROCEDURES
Channel Expression in Xenopus Oocytes
Constructs containing the sequenceof the humanHv1channelwere generated
from cDNA kindly provided by David Clapham (Ramsey et al., 2006) and from
IMAGE clone 5577070 (Open Biosystems). The cDNAs for Ci-VSP and Ci-
VSOP were gifts from Yasushi Okamura (Murata et al., 2005; Sasaki et al.,
2006). The cDNA for Eh-HVCN1 codon-optimized for expression inmammalian
cells and Xenopus oocytes was kindly provided by Colin Brownlee and Glen
Wheeler (Taylor et al., 2011). With the exception of Ci-VSOP, all the constructs
were subcloned in the pGEMHE vector (Liman et al., 1992) by the SOEing tech-
nique (Horton et al., 1990). In the NVSP-Hv1-CVSP chimera, residues 1–96 and
228–273 of Hv1 were replaced by residues 1–113 and 240–576 of Ci-VSP,
respectively. Single point mutations were introduced with standard PCR tech-
niques. In theHv1 linked dimers, the two consecutive subunitswere connected
by the sequence GGSGGSGGSGGSGGSGG (Tombola et al., 2008).
Plasmids were linearized with either NheI or SphI restriction enzymes (New
England Biolabs) before in vitro transcription. RNA synthesis was carried out
with a T7 mMessage mMachine transcription kit (Ambion). Ci-VSOP was in
the pSD64TF expression vector (Krieg and Melton, 1984). The linearized
plasmid was transcribed with SP6 RNA polymerase. cRNAs were injected in
Xenopus oocytes (50 nl per cell, 0.3–1.5 mg/ml) 1–3 days before the electro-
physiological measurements. Cells were kept at 18C in ND96 medium con-
taining 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 10 mM HEPES,
5 mM pyruvate, 100 mg/ml gentamycin (pH 7.2).
Hv1 Inhibitors
All the compounds tested were at the highest purity commercially available.
Guanidine hydrochloride was from MP Biomedicals. Aminoguanidine hydro-
chloride was from Acros Organics. 2-aminoimidazole sulfate, 2-aminopyrimi-
dine, agmatine sulfate, 2-aminobenzimidazole, 2-guanidinobenzimidazole,1,1-dimethylbiguanide hydrochloride, 2-guanidino-4-methylquinazoline hy-
drochloride, and N-(guanidino-imino-methyl)-N-phenylacetamide hydrochlo-
ride, were from Sigma-Aldrich. 1-(1,3-benzoxazol-2-yl)guanidine and 1-(1,3-
benzothiazol-2-yl)guanidine were from both ChemDiv and Sigma-Aldrich.
The compounds were directly dissolved in the recording solutions at the
desired final concentrations or prepared as 1003 stock solutions in the
same medium. To keep GBOZ in solution at the highest concentrations tested
on WT Hv1 channels, DMSO was added to a maximal ratio of 5% v/v for the
4 mM solution. We tested recording solutions with DMSO up to 10% v/v on
inside-out patches containing Hv1 channels, and 5% was the maximal ratio
that we were able to use without altering the measured proton currents or
compromising the stability of the patch under perfusion.
We estimated the pKa of the guanidinium group of the tested inhibitors using
the pKa calculation plugin of Marvin (http://www.ChemAxon.com). With the
exception of 2-aminopyrimidine, the compounds were predicted to be
primarily in the protonated and positively charged form at pH = 6.0. Com-
pounds 7, 11, and 12 were also analyzed as free ligands in PROPKA3.1
(http://propka.ki.ku.dk) (Sondergaard et al., 2011). A charge of +1 was pre-
dicted for the three molecules under the pH conditions used for the
measurements.
Patch-Clamp Measurements
Electrophysiological measurements on oocytes were performed in inside-out
and outside-out patch configurations using an Axopatch 200B amplifier
controlled by pClamp10 software through an Axon Digidata 1440A (Molecular
Devices). Unless otherwise specified, the bath solution contained 100 mM
2-(N-morpholino)ethanesulphonic acid (MES), 30 mM tetraethylammonium
(TEA) methanesulfonate, 5 mM TEA chloride, 5 mM ethyleneglycol-bis(2-ami-
noethyl)-N,N,N0,N0-tetra-acetic acid (EGTA), adjusted to pH 6.0 with TEA
hydroxide. For recordings carried out in the absence of pH gradient (pHi =
pHo = 6.0), the pipette solution had the same composition of the bath solu-
tion. Some of the measurements were performed in the presence of a pH
gradient (pHi = 6.0, pHo = 7.5). In these cases the extracellular solution con-
tained 100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
40 mM TEA methanesulfonate, 5 mM TEA chloride, adjusted to pH 7.5 with
TEA hydroxide. All measurements were performed at 22C ± 2C. Pipettes
had 2–4 MU access resistance. Current traces were filtered at 1 kHz, sampled
at 5 kHz and analyzed with Clampfit10.2 (Molecular Devices) and Origin8.1
(OriginLab).
Modeling of Channel Block
The process of channel block in dimeric and monomeric Hv1 was simulated
with Berkeley Madonna 8.3 using the Runge-kutta 4 integration method
(Macey et al., 2009). The model calculated the proton current in response to
different voltage protocols in the absence and presence of 2GBI. The values
of the rate constants used to generate the traces in Figures 6B–6D and S3
are reported in Figure S4. Dimeric channels were modeled by six distinct
states (CC, OC, OO, BC, BO, BB), which took into account the fact that states
OB, CB, and CO are equivalent to states BO, BC, and OC, respectively. Thus,
at any point of time the total number of channels was represented by N =NCC +
NOO + NBB + 2NOC + 2NBO + 2NBC.
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